When we think about nutrients associated with brain health, omega-3 fatty acids, B vitamins, vitamin D and magnesium usually dominate the conversation.
Vitamin K rarely makes the list.
Most of us associate vitamin K with blood clotting, bone health and, more recently, preventing calcium from accumulating in our arteries.
But what if vitamin K also plays a meaningful role in maintaining the biological systems that become particularly vulnerable in people who carry the APOE4 gene?
I’m continually exploring the molecular pathways that contribute to Alzheimer’s disease risk. I want to understand how the biology works - and identifying where we might reasonably intervene - and where are efforts give us the most “bang for the buck”.
Vitamin K caught my attention early on. Several of its functions intersect with pathways implicated in APOE4-associated neurodegeneration.
The science is fascinating, although far from conclusive.
Vitamin K Is Not Just a Vitamin
Vitamin K is actually a family of fat-soluble compounds, primarily divided into two groups.
Vitamin K1 (phylloquinone) is found predominantly in leafy green vegetables, including kale, spinach, broccoli and cabbage.
Vitamin K2 (menaquinones) includes several forms, notably MK-4 and MK-7.
MK-4 is found in certain animal foods and can also be produced within our tissues through conversion of vitamin K precursors.
MK-7 is commonly associated with fermented foods, particularly natto, a traditional Japanese soybean product which I’ve written about before.
These forms differ in their absorption, distribution and circulation time.
Interestingly, MK-4 is found in the brain, where vitamin K is involved in biological processes extending well beyond coagulation, but we cannot automatically assume that all forms of vitamin K have identical neurological effects.
1. APOE4, Vitamin K Transport and Lipid Metabolism
This may be the most intriguing connection of all.
APOE is fundamentally a lipid-transport protein. It helps move cholesterol and other lipids between cells, particularly within the central nervous system.
APOE4 alters several aspects of lipid handling and is associated with disturbances in neuronal membranes, inflammation and cellular repair.
Vitamin K is also transported through the body in association with lipoproteins.
After intestinal absorption, dietary vitamin K travels initially in chylomicrons and subsequently through other lipoprotein pathways.
APOE participates in the clearance of these particles.
Researchers have therefore proposed that APOE genotype might influence vitamin K transport, circulation and tissue availability. An early hypothesis suggested that APOE4-associated differences in lipoprotein clearance could contribute to lower circulating vitamin K concentrations.
A 2026 review revisited this possibility, highlighting the potential relationship between APOE polymorphisms, vitamin K metabolism and Alzheimer’s disease. However, this remains a hypothesis rather than an established explanation for vitamin K status in APOE4 carriers.
We do not yet know whether APOE4 carriers consistently have lower vitamin K availability within the brain, or whether increasing vitamin K intake could correct any such difference. Still, the intersection is very interesting and begs more research.
If APOE4 changes how lipids are transported and distributed, could it also influence how a fat-soluble nutrient involved in neuronal maintenance reaches its destination?
That is a question I would love to see addressed in genotype-specific clinical studies.
2. Vitamin K and Sphingolipids: Protecting Neuronal Architecture
The brain is extraordinarily rich in lipids. These aren’t simply energy reserves. They are structural components of neuronal membranes, myelin and the complex signaling systems that allow neurons to communicate.
Among the most important are sphingolipids. They contribute to membrane stability, cellular recognition, signaling and the integrity of myelin sheaths surrounding nerve fibers. Disturbances in sphingolipid metabolism have been implicated in Alzheimer’s disease.
Vitamin K has a recognized role in regulating sphingolipid metabolism, supported particularly by experimental research.
This creates an interesting potential intersection with APOE4.
APOE4 is associated with abnormalities in lipid trafficking and membrane homeostasis. Vitamin K participates in pathways involved in maintaining certain neuronal lipids.
Could adequate vitamin K status help support membrane function in a brain already challenged by APOE4-related lipid dysregulation? Is this why we’re told to eat plenty of dark green leafy vegetables?
Biologically, the question is reasonable.
3. Gas6, Protein S and the Blood-Brain Barrier
One of the biological vulnerabilities associated with APOE4 involves the blood-brain barrier (BBB). It’s a highly specialized network of endothelial cells, pericytes, astrocytes and supporting structures that regulates what enters and leaves the brain. It’s the brain’s gatekeeper. Its integrity is essential for protecting neurons from potentially harmful circulating substances and maintaining a stable environment.
APOE4 has been linked to blood-brain barrier dysfunction, including changes in pericyte signaling and inflammatory pathways.
Vitamin K enters this discussion through two vitamin K-dependent proteins:
Growth arrest-specific protein 6 (Gas6)
Protein S
Both participate in signaling through the TAM family of receptors, which includes Tyro3, Axl and MerTK and these pathways influence cell survival, immune regulation and the clearance of cellular debris.
Gas6 signaling has been investigated for its potential roles in neuronal protection and glial function.
Protein S also has functions extending beyond its familiar role in blood coagulation.
The intriguing possibility is that vitamin K availability could influence the activity of proteins participating in processes relevant to neurovascular health.
For APOE4 carriers, the relationship deserves investigation precisely because blood-brain barrier dysfunction may be one of the early contributors to neurodegeneration.
4. Vitamin K, Microglia and Neuroinflammation
Microglia are the brain’s resident immune cells. They help maintain brain health by removing damaged cellular material, responding to injury and participating in the maintenance of neural networks. But chronically activated or dysfunctional microglia may contribute to neuroinflammation.
APOE4 influences aspects of microglial biology and inflammatory signaling, making immune regulation particularly relevant to Alzheimer’s research. The vitamin K-dependent Gas6 and protein S pathways interact with TAM receptors involved in immune-cell regulation and the recognition of material that needs to be cleared.
These systems can help regulate inflammatory responses and cellular housekeeping.
The most scientifically defensible conclusion is that vitamin K-dependent proteins participate in immune processes relevant to brain health - not that vitamin K supplementation has been shown to suppress APOE4-related neuroinflammation.
5. Ferroptosis: A Particularly Fascinating Discovery
This is where vitamin K research becomes especially interesting.
In 2022, researchers published a study in Nature identifying a previously underappreciated role for vitamin K in protecting cells against ferroptosis.
Ferroptosis is a form of regulated cell death driven by iron-dependent lipid peroxidation.
Unlike apoptosis, ferroptosis involves the destructive oxidation of membrane lipids.
This matters because oxidative lipid damage, impaired antioxidant defenses and iron dysregulation have all been investigated in neurodegenerative disease. Researchers discovered that ferroptosis suppressor protein 1 (FSP1) can convert vitamin K into a reduced form capable of trapping damaging lipid radicals.
In experimental systems, this vitamin K recycling pathway helped protect cells against ferroptotic damage.
Think about the possible intersection with APOE4.
We have a genotype associated with altered lipid metabolism and vulnerability to cellular stress.
We have a nutrient whose reduced form can participate in protecting lipids against oxidative destruction.
And we have a form of cell death increasingly investigated in neurodegeneration.
The overlap is compelling.
However, the discovery does not establish that taking vitamin K prevents neuronal ferroptosis in humans or reduces Alzheimer’s risk. It also does not tell us which vitamin K supplement, if any, would be most effective.
Nevertheless, this is one of the strongest mechanistic reasons I believe vitamin K deserves greater attention in brain-aging research and why I have been taking a Vitamin K supplement since 2020.
6. Vascular Health: Another Potential Piece of the Puzzle
Alzheimer’s disease is not exclusively a disease of amyloid and tau. As we know, vascular health also matters.
Reduced cerebral perfusion, endothelial dysfunction and small-vessel disease can contribute to cognitive impairment.
For APOE4 carriers, preserving vascular integrity may be particularly important because vascular dysfunction can interact with other disease mechanisms.
Vitamin K is required to activate matrix Gla protein (MGP), a protein involved in inhibiting inappropriate calcification in soft tissues and blood vessels.
Inadequate vitamin K availability can reduce the activation of this protein.
Preventing vascular calcification is not the same as improving cerebral blood flow, and we cannot assume that increasing vitamin K intake will reverse existing calcification or prevent dementia. The mechanistic connection is nevertheless worth studying and at my age, I see no downside to Vitamin K intake in moderation.
7. A Surprising 2026 Study: K1 and K2 Show Opposite Associations
One of the most interesting developments comes from a large Danish study published in the European Journal of Nutrition in August 2026.
Researchers analyzed dietary vitamin K intake in 54,968 adults, following participants for as long as 28 years.
During follow-up, 4,802 participants developed dementia.
The researchers examined vitamin K1 and K2 separately.
Their findings were surprising.
Participants in the highest category of dietary vitamin K1 intake had a 14% lower relative rate of dementia compared with those consuming the least.
But higher dietary vitamin K2 intake was associated with a 14% higher relative rate of dementia.
That seems counterintuitive.
After all, K2 has attracted considerable attention for its potential cardiovascular benefits, and laboratory studies have suggested neuroprotective properties.
Does this mean K1 protects the brain while K2 harms it? Absolutely not.
This was an observational study. Dietary vitamin K1 comes largely from vegetables and plant-based foods, while K2 intake in this population was associated more strongly with animal-derived foods.
The study’s K2 intake was driven substantially by MK-4, with dairy-associated menaquinones also contributing. These dietary patterns may reflect differences in other nutrients, food processing, lifestyle or health behaviors.
Although researchers adjusted for numerous variables, residual confounding remains possible.
Importantly, the study did not establish the effects of isolated MK-7 supplements, and it did not demonstrate that vitamin K2 causes dementia.
The findings also cannot tell us whether APOE4 carriers respond differently because the reported analysis did not establish genotype-specific effects.
What I find most interesting is that the results challenge the assumption that all forms of vitamin K should be treated interchangeably. They also remind us why mechanistic findings and observational studies must eventually be tested in randomized clinical trials.
8. What About Vitamin K2 Supplements?
MK-4 and MK-7 are frequently marketed for cardiovascular and bone health.
MK-7 has a relatively long circulating half-life, while MK-4 has different tissue-distribution and metabolic characteristics.
These differences are scientifically interesting, but they do not establish which form is preferable for potential Alzheimer’s prevention.
These findings provide a rationale for further research.
9. What Does This Mean for APOE4 Carriers Today?
For now, I believe the most reasonable approach is to ensure adequate vitamin K intake through a nutrient-dense diet rather than assume that higher-dose supplementation will provide additional protection.
The U.S. National Institutes of Health establishes an adequate intake of:
90 micrograms daily for adult women
120 micrograms daily for adult men
These recommendations are intended to support nutritional adequacy, not specifically to prevent dementia.
Vitamin K1-rich foods include kale, spinach, collard greens, broccoli and other leafy vegetables.
Because vitamin K is fat-soluble, eating these vegetables with some dietary fat can improve absorption.
For example, a spinach salad dressed with extra-virgin olive oil provides both vitamin K and a dietary pattern associated with cardiovascular health.
For people taking warfarin or similar vitamin K antagonist medications, maintaining a consistent vitamin K intake is essential. Significant dietary or supplement changes should be discussed with the prescribing clinician.
APOE4 is a genetic risk factor, not an inevitable outcome. Understanding the pathways it affects gives us a better foundation for evaluating what might actually help.
And vitamin K deserves a place in that scientific conversation.
Scientific References
Ghasemifard N, et al. (2026). Associations between dietary vitamin K1 and K2 intake and incident dementia: findings from the Danish Diet, Cancer, and Health cohort. European Journal of Nutrition.
https://pubmed.ncbi.nlm.nih.gov/42560451/Mishima E, et al. (2022). A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature.
https://doi.org/10.1038/s41586-022-05022-3Jackson RJ, Hyman BT, Serrano-Pozo A. (2024). Multifaceted roles of APOE in Alzheimer disease. Nature Reviews Neurology.
https://doi.org/10.1038/s41582-024-00988-2Miteva K, et al. (2026). Vitamin deficiencies and Alzheimer’s disease: evidence and implications for supplementation.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12947704/National Institutes of Health, Office of Dietary Supplements. Vitamin K: Fact Sheet for Health Professionals.
https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/
Disclaimer: This article is an exploration of emerging scientific research, not medical advice. Mechanistic findings and observational associations should not be interpreted as proof that vitamin K supplementation prevents or treats Alzheimer’s disease.